ELUTIA INC. — Director's Dealing 2022

Oct 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2022-10-20

Reporting Person: Williams Michelle LeRoux (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-20	Stock Option (Right to Buy)	$7.16	A	90000	Acquired	2032-10-20	Class A Common Stock (90000)	Direct

Footnotes

F1: The option vests as to 25% of the shares on October 20, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on October 20, 2026.